Malini Pasricha, MD
Retina Specialist · San Francisco, CANPI 1215469606
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,301 of the $13,399 with a category attached, or 62.0%. Genentech USA, Inc. accounts for 72.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2024 at $7,779 and has fallen 91.4% since, to $667 in 2025.
Across 63 payments — averaging $212.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$10K
- Regeneron Healthcare Solutions, Inc.$2K
- Genentech, Inc.$451
- Amgen$217
- AbbVie$203
- Apellis Pharmaceuticals, Inc.$182
- plus $1K from 11 others
Across 1 payment — averaging $13,666 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$14K
What the payments were for
- Consulting fees$8,30162%
- Travel & lodging$1,1439%
- Food & beverage$3,95530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 26 | $9,701 |
| Regeneron Healthcare Solutions, Inc. | 12 | $1,563 |
| Genentech, Inc. | 6 | $451 |
| Amgen | 2 | $217 |
| AbbVie(2 entities) | 4 | $203 |
| Apellis Pharmaceuticals, Inc. | 2 | $182 |
| Glaukos Corporation | 1 | $177 |
| Dutch Ophthalmic, USA | 1 | $149 |
| Carl Zeiss Meditec USA, Inc. | 1 | $137 |
| Aerie Pharmaceuticals, Inc. | 1 | $117 |
| Rxsight Inc | 1 | $114 |
| Bausch & Lomb Americas Inc. | 1 | $109 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $93 |
| Alimera Sciences, Inc. | 1 | $81 |
| Neurotech Pharmaceuticals, Inc. | 1 | $49 |
| Astellas Pharma US Inc | 1 | $34 |
| Regeneron | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$9,112
- EYLEA HD$1,086
- EYLEA$238
- Photrexa Viscous and Photrexa$177
- EVA, combined machine$149
- TEPEZZA$147
- SUSVIMO$144
- ARTEVO 800$137
- Lucentis$125
- Rhopressa$117
- Rocklatan$117
- OZURDEX$115
- RXSIGHT CONTACT LENS$114
- RXSIGHT INJECTOR CARTRIDGE$114
- RXSIGHT INJECTOR HANDPIECE$114
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$114
- LIGHT ADJUSTABLE LENS (LAL)$114
- STELLARIS$109
- enVista MX60 IOL$109
How this compares
$13,399 in reported general payments places this provider in the 75th percentile of 187 retina specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 54 | $3,210 |
| Bromfenac Sodium | 21 | $2,497 |
| Difluprednate | 16 | $1,787 |
| Ketorolac Tromethamine | 25 | $616 |
| Latanoprost | 24 | $190 |
| MoxifloxacinMoxifloxacin Hcl | 12 | $190 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 20 | $154 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in San Francisco
- Judy ChenSan Francisco$15K
- Andrew CalmanSan Francisco$13K
- James JumperSan Francisco$13K
- Dilsher DhootSanta Barbara$1.9M
- Ehsan RahimyStanford$1.5M
- Darius MoshfeghiPalo Alto$1.4M
- Nathan SteinleSanta Barbara$1.1M
- Roger GoldbergWalnut Creek$1.1M
- Baruch KuppermannIrvine$1M
- Carlos Medina MendezSacramento$548K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.